Combined with the expression analysis of TRAIL-related death receptors via the TCGA dataset and the results of TRAIL-induced apoptosis in glioma cell lines (Figure 4A, 4B, Figure S4), it was concluded that TRAIL may facilitate targeting and apoptosis induction in glioblastoma therapies. The gene discussed is TNFSF10; the disease is central nervous system cancer.